These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17073624)

  • 1. Engineered T cell receptors and their potential in molecular medicine.
    Miles JJ; Silins SL; Burrows SR
    Curr Med Chem; 2006; 13(23):2725-36. PubMed ID: 17073624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.
    Boulter JM; Jakobsen BK
    Clin Exp Immunol; 2005 Dec; 142(3):454-60. PubMed ID: 16297157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer T-cells and T-cell receptors for customized cancer immunotherapies.
    Legut M; Sewell AK
    Curr Opin Pharmacol; 2018 Aug; 41():96-103. PubMed ID: 29852403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble T cell receptors: novel immunotherapies.
    Molloy PE; Sewell AK; Jakobsen BK
    Curr Opin Pharmacol; 2005 Aug; 5(4):438-43. PubMed ID: 15939669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting domains for chimeric antigen receptor T cells.
    Bezverbnaya K; Mathews A; Sidhu J; Helsen CW; Bramson JL
    Immunotherapy; 2017 Jan; 9(1):33-46. PubMed ID: 28000526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity, immunologic tolerance, and gene therapy.
    Chen Y
    Immunol Res; 1998; 17(1-2):33-40. PubMed ID: 9479565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases].
    Vdovin AS; Bykova NA; Efimov GA
    Mol Biol (Mosk); 2017; 51(6):1008-1023. PubMed ID: 29271964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supernatural T cells: genetic modification of T cells for cancer therapy.
    Kershaw MH; Teng MW; Smyth MJ; Darcy PK
    Nat Rev Immunol; 2005 Dec; 5(12):928-40. PubMed ID: 16322746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.
    Chicaybam L; Sodré AL; Bonamino M
    Int Rev Immunol; 2011; 30(5-6):294-311. PubMed ID: 22053970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer immunotherapy using gene-engineered T cells].
    Kageyama S
    Rinsho Ketsueki; 2018; 59(2):216-224. PubMed ID: 29515077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ImmTACs for targeted cancer therapy: Why, what, how, and which.
    Oates J; Hassan NJ; Jakobsen BK
    Mol Immunol; 2015 Oct; 67(2 Pt A):67-74. PubMed ID: 25708206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for immunotherapy directed to the T cell receptor in human autoimmune disease.
    Steinman L
    Ann N Y Acad Sci; 1991 Dec; 636():147-53. PubMed ID: 1724361
    [No Abstract]   [Full Text] [Related]  

  • 13. T cell receptors and cancer: gain gives pain.
    Brenner M
    Nat Med; 2010 May; 16(5):520-1. PubMed ID: 20448573
    [No Abstract]   [Full Text] [Related]  

  • 14. Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.
    Sauer EL; Cloake NC; Greer JM
    Int Rev Immunol; 2015; 34(6):460-85. PubMed ID: 25970132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
    Lin C; Zhang J
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapeutic potential of bispecific antibodies.
    van de Winkel JG; Bast B; de Gast GC
    Immunol Today; 1997 Dec; 18(12):562-4. PubMed ID: 9425731
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigen-receptor gene-modified T cells for treatment of glioma.
    Ikeda H; Shiku H
    Adv Exp Med Biol; 2012; 746():202-15. PubMed ID: 22639170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.
    Shum T; Kruse RL; Rooney CM
    Expert Opin Biol Ther; 2018 Jun; 18(6):653-664. PubMed ID: 29727246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer.
    Magee MS; Snook AE
    Discov Med; 2014 Nov; 18(100):265-71. PubMed ID: 25425467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor gene therapy for autoimmune diseases.
    Fujio K; Okamura T; Okamoto A; Yamamoto K
    Ann N Y Acad Sci; 2007 Sep; 1110():222-32. PubMed ID: 17911437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.